Patents by Inventor Geunho KANG

Geunho KANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microfluidic system, method for inhibiting, delaying, or reversing cellular senescence using microfluidic system, and cell obtained therefrom
    Patent number: 11951479
    Abstract: The present invention relates to a method of inhibiting, delaying, or reversing cellular senescence that includes having an isolated cell flow through a microchannel, and crashing the cell in flow into an impact surface installed on a flow path of the cell to apply a physical impact to the cell, resulting in inhibiting, delaying, or reversing senescence of the cell, while maintaining high biological activity, and in particular, it relates to a method that can further increase the value of a stem cell as a therapeutic cell for various degenerative diseases by maintaining undifferentiated state of the stem cell even during a long-term culture period to maintain multipotency, and to the cells obtained by the method.
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: April 9, 2024
    Assignees: KONKUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
    Inventors: Ssang-Goo Cho, Aram Chung, Kyung Min Lim, Geunho Kang, Soobin Jang
  • MICROFLUIDIC SYSTEM, METHOD FOR INHIBITING, DELAYING, OR REVERSING CELLULAR SENESCENCE USING MICROFLUIDIC SYSTEM, AND CELL OBTAINED THEREFROM
    Publication number: 20220032304
    Abstract: The present invention relates to a method of inhibiting, delaying, or reversing cellular senescence that includes having an isolated cell flow through a microchannel, and crashing the cell in flow into an impact surface installed on a flow path of the cell to apply a physical impact to the cell, resulting in inhibiting, delaying, or reversing senescence of the cell, while maintaining high biological activity, and in particular, it relates to a method that can further increase the value of a stem cell as a therapeutic cell for various degenerative diseases by maintaining undifferentiated state of the stem cell even during a long-term culture period to maintain multipotency, and to the cells obtained by the method.
    Type: Application
    Filed: July 29, 2021
    Publication date: February 3, 2022
    Inventors: Ssang-Goo CHO, Aram CHUNG, Kyung Min LIM, Geunho KANG, Soobin JANG